About CellCentric
CellCentric is a clinical-stage biopharmaceutical company that develops inobrodib, an oral small molecule inhibitor. This drug is designed to treat multiple myeloma and other cancers by disrupting the growth of cancer cells. CellCentric aims to develop inobrodib for the benefit of patients and physicians.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Cambridge, United Kingdom
Team Size
11-50
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
cellcentric.com
Domain Registered Date
Nov 2, 2003
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $220,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $120,000,000 · Series-B+
- Milestone
X account created (@CellCentric)
702 followers
- Milestone
Website domain registered
cellcentric.com
Investors & Backers
Avego Bioscience Capital
Avego Management
BrightEdge - American Cancer Society
Fidelity
Forbion Capital Partners
HBM Healthcare Investments
Pfizer Venture Investments
RA Capital Management
Sofinnova Partners
Venrock Healthcare Capital Partners
Funding History
Series-B+
· May 6, 2026
$220,000,000 fundraisingfox.com
Series-B+
· May 19, 2025
$120,000,000 Source
Founders & Leadership
Azim Surani
Founder
Work email & phone locked
Unlock →
Celia Economides
Chief Financial Officer and Chief Business Officer
Work email & phone locked
Unlock →
Karen Clegg
Clinical Science Director
Work email & phone locked
Unlock →
Thea Stanway
Finance Director & Company Secretary
Work email & phone locked
Unlock →
Will West
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026